Athyrium Opportunities Associates Iii Gp Llc - Net Worth and Insider Trading
Athyrium Opportunities Associates Iii Gp Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Athyrium Opportunities Associates Iii Gp Llc owns 1 companies in total, including Biora Therapeutics Inc (BIOR) .
Insider Ownership Summary of Athyrium Opportunities Associates Iii Gp Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
BIOR | Biora Therapeutics Inc | 2020-06-18 | 10 percent owner |
Athyrium Opportunities Associates Iii Gp Llc Trading Performance
Athyrium Opportunities Associates Iii Gp Llc Ownership Network
Ownership Network List of Athyrium Opportunities Associates Iii Gp Llc
Ownership Network Relation of Athyrium Opportunities Associates Iii Gp Llc
Athyrium Opportunities Associates Iii Gp Llc Owned Company Details
What does Biora Therapeutics Inc do?
Who are the key executives at Biora Therapeutics Inc?
Athyrium Opportunities Associates Iii Gp Llc is the 10 percent owner of Biora Therapeutics Inc. Other key executives at Biora Therapeutics Inc include 10 percent owner Athyrium Opportunities Iii Co-invest 1 Lp , director & Chief Executive Officer Aditya P. Mohanty , and 10 percent owner Athyrium Capital Management, Lp .
Biora Therapeutics Inc (BIOR) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Biora Therapeutics Inc (BIOR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biora Therapeutics Inc (BIOR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Biora Therapeutics Inc (BIOR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biora Therapeutics Inc Insider Transactions
Athyrium Opportunities Associates Iii Gp Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Athyrium Opportunities Associates Iii Gp Llc. You might contact Athyrium Opportunities Associates Iii Gp Llc via mailing address: 505 Fifth Avenue, Floor 18, New York Ny 10017.